Literature DB >> 15664932

The Salmonella enterica serovar typhimurium-encoded type III secretion systems can translocate Chlamydia trachomatis proteins into the cytosol of host cells.

Theresa D Ho1, Michael N Starnbach.   

Abstract

Chlamydia trachomatis is an obligate, intracellular pathogen that is a major cause of preventable blindness and infertility worldwide. Although the published genome sequence suggests that C. trachomatis encodes a type III secretion system, the lack of genetic tools for studying Chlamydia has hindered the examination of this potentially important class of virulence genes. We have developed a technique to identify Chlamydia proteins that can be translocated into the host cell cytoplasm by a type III secretion system. We have selected several Chlamydia proteins and tagged them with a multiple peptide motif element called F8M4. Epitopes contained in the F8M4 tag allow us to use tools corresponding to different arms of the adaptive immune system to detect the expression and translocation of these proteins by Salmonella enterica serovar Typhimurium. In particular, CD8(+)-T-cell reactivity can be used to detect the translocation of F8M4-tagged proteins into the cytoplasm of host cells. We have found that CD8(+)-T-cell activity assays are sensitive enough to detect translocation of even a small amount of F8M4-tagged protein. We have used CD8(+)-T-cell activity to show that CopN, a Chlamydia protein previously shown to be translocated by Yersinia type III secretion, can be translocated by the Salmonella pathogenicity island 1 (SPI-1) type III secretion system. Additionally, we demonstrate that CopD and Pkn5, two Chlamydia proteins hypothesized to be substrates of a type III secretion system, are translocated via the SPI-2 type III secretion system of serovar Typhimurium. The epitope tag system described here can be used more generally to examine the expression and subcellular compartmentalization of bacterial proteins deployed during the interaction of pathogens with mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664932      PMCID: PMC547017          DOI: 10.1128/IAI.73.2.905-911.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Type III secretion system in Chlamydia species: identified members and candidates.

Authors:  A Subtil; A Blocker; A Dautry-Varsat
Journal:  Microbes Infect       Date:  2000-04       Impact factor: 2.700

2.  Revisiting the chlamydial type III protein secretion system: clues to the origin of type III protein secretion.

Authors:  J F Kim
Journal:  Trends Genet       Date:  2001-02       Impact factor: 11.639

3.  Salmonella pathogenicity island 1-independent induction of apoptosis in infected macrophages by Salmonella enterica serotype typhimurium.

Authors:  A W van der Velden; S W Lindgren; M J Worley; F Heffron
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Comparative proteome analysis of Chlamydia trachomatis serovar A, D and L2.

Authors:  Allan C Shaw; Kris Gevaert; Hans Demol; Bart Hoorelbeke; Joël Vandekerckhove; Martin R Larsen; Peter Roepstorff; Arne Holm; Gunna Christiansen; Svend Birkelund
Journal:  Proteomics       Date:  2002-02       Impact factor: 3.984

Review 5.  Salmonella pathogenicity islands encoding type III secretion systems.

Authors:  I Hansen-Wester; M Hensel
Journal:  Microbes Infect       Date:  2001-06       Impact factor: 2.700

6.  Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery.

Authors:  A Subtil; C Parsot; A Dautry-Varsat
Journal:  Mol Microbiol       Date:  2001-02       Impact factor: 3.501

7.  Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library.

Authors:  J C Goodall; G Yeo; M Huang; R Raggiaschi; J S Gaston
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

8.  Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996.

Authors:  S L Groseclose; A A Zaidi; S J DeLisle; W C Levine; M E St Louis
Journal:  Sex Transm Dis       Date:  1999-07       Impact factor: 2.830

9.  Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism.

Authors:  K A Fields; T Hackstadt
Journal:  Mol Microbiol       Date:  2000-12       Impact factor: 3.501

10.  A conserved amino acid sequence directing intracellular type III secretion by Salmonella typhimurium.

Authors:  E A Miao; S I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

View more
  25 in total

1.  SepL resembles an aberrant effector in binding to a class 1 type III secretion chaperone and carrying an N-terminal secretion signal.

Authors:  Rasha Younis; Lewis E H Bingle; Sarah Rollauer; Diana Munera; Stephen J Busby; Steven Johnson; Janet E Deane; Susan M Lea; Gad Frankel; Mark J Pallen
Journal:  J Bacteriol       Date:  2010-09-10       Impact factor: 3.490

2.  Identification of a family of effectors secreted by the type III secretion system that are conserved in pathogenic Chlamydiae.

Authors:  Sandra Muschiol; Gaelle Boncompain; François Vromman; Pierre Dehoux; Staffan Normark; Birgitta Henriques-Normark; Agathe Subtil
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis.

Authors:  Sandra Muschiol; Leslie Bailey; Asa Gylfe; Charlotta Sundin; Kjell Hultenby; Sven Bergström; Mikael Elofsson; Hans Wolf-Watz; Staffan Normark; Birgitta Henriques-Normark
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

4.  A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.

Authors:  Jie Wang; Lili Chen; Fan Chen; Xiaoyun Zhang; Yingqian Zhang; Joel Baseman; Sondra Perdue; I-Tien Yeh; Rochelle Shain; Martin Holland; Robin Bailey; David Mabey; Ping Yu; Guangming Zhong
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

5.  The Chlamydia effector chlamydial outer protein N (CopN) sequesters tubulin and prevents microtubule assembly.

Authors:  Tara L Archuleta; Yaqing Du; Chauca A English; Stephen Lory; Cammie Lesser; Melanie D Ohi; Ryoma Ohi; Benjamin W Spiller
Journal:  J Biol Chem       Date:  2011-08-13       Impact factor: 5.157

6.  Expression and targeting of secreted proteins from Chlamydia trachomatis.

Authors:  Laura D Bauler; Ted Hackstadt
Journal:  J Bacteriol       Date:  2014-01-17       Impact factor: 3.490

7.  Interactions between CdsD, CdsQ, and CdsL, three putative Chlamydophila pneumoniae type III secretion proteins.

Authors:  Dustin L Johnson; Chris B Stone; James B Mahony
Journal:  J Bacteriol       Date:  2008-02-15       Impact factor: 3.490

8.  The Chlamydia type III secretion system C-ring engages a chaperone-effector protein complex.

Authors:  Kris E Spaeth; Yi-Shan Chen; Raphael H Valdivia
Journal:  PLoS Pathog       Date:  2009-09-11       Impact factor: 6.823

9.  Biophysical characterization of Chlamydia trachomatis CT584 supports its potential role as a type III secretion needle tip protein.

Authors:  Aaron P Markham; Zane A Jaafar; Kyle E Kemege; C Russell Middaugh; P Scott Hefty
Journal:  Biochemistry       Date:  2009-11-03       Impact factor: 3.162

10.  Polymorphisms in inc proteins and differential expression of inc genes among Chlamydia trachomatis strains correlate with invasiveness and tropism of lymphogranuloma venereum isolates.

Authors:  Filipe Almeida; Vítor Borges; Rita Ferreira; Maria José Borrego; João Paulo Gomes; Luís Jaime Mota
Journal:  J Bacteriol       Date:  2012-10-05       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.